LONDON--(BUSINESS WIRE)-- BTG plc (BTG.L), the global specialist healthcare company, today announced U.S. Food and Drug Administration 510(k) clearance has been granted to the EKOS® Control Unit 4.0. The EKOS® system includes an ultrasonic device that uses acoustic pulses, powered by the new Control Unit 4.0, to quickly and safely dissolve blood clots and restore [...]
The post BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0 appeared first on Strategic.